BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gordon-walker TT, Bove K, Veldtman G. Fontan-associated liver disease: A review. Journal of Cardiology 2019;74:223-32. [DOI: 10.1016/j.jjcc.2019.02.016] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Padalino MA, Ponzoni M, Castaldi B, Leoni L, Chemello L, Toscano G, Gerosa G, Di Salvo G, Vida VL. Surgical management of failing Fontan circulation: results from 30 cases with 285 patient-years follow-up. Eur J Cardiothorac Surg 2021:ezab450. [PMID: 34687535 DOI: 10.1093/ejcts/ezab450] [Reference Citation Analysis]
2 Lu SF, Joseph KM, Banayan JM. Anesthetic considerations for Fontan circulation and pregnancy. Int Anesthesiol Clin 2021;59:52-9. [PMID: 34029248 DOI: 10.1097/AIA.0000000000000329] [Reference Citation Analysis]
3 Kaulitz R, Ziemer G, Hofbeck M. Off-pump direct hepatic veins-to-hemiazygos vein anastomosis after primary Kawashima operation: long-term result. Cardiol Young 2021;:1-3. [PMID: 33682660 DOI: 10.1017/S1047951121000421] [Reference Citation Analysis]
4 Than PA, Brubaker AL, Ebel NH, Profita EL, Esquivel CO. The Emerging Need for Combined Heart and Liver Transplantation in Congenital Heart Disease. Curr Transpl Rep 2020;7:180-6. [DOI: 10.1007/s40472-020-00286-y] [Reference Citation Analysis]
5 Guruchandrasekar SH, Dakin H, Kadochi M, Bhatia A, Bardales L, Johnston M, Piggott KD. Pre-Fontan Cardiac Catheterization Data as a Predictor of Prolonged Hospital Stay and Post-Discharge Adverse Outcomes Following the Fontan Procedure: A Single-Center Study. Pediatr Cardiol 2020;41:1697-703. [PMID: 32734530 DOI: 10.1007/s00246-020-02430-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sakamori R, Yamada R, Tahata Y, Kodama T, Hikita H, Tatsumi T, Yamada T, Takehara T. The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery. J Gastroenterol. [DOI: 10.1007/s00535-021-01842-8] [Reference Citation Analysis]
7 Khan S, Aziz H, Emamaullee J. Research priorities in Fontan-associated liver disease. Curr Opin Organ Transplant 2020;25:489-95. [PMID: 32833705 DOI: 10.1097/MOT.0000000000000803] [Reference Citation Analysis]
8 Hedlund E, Lundell B. Fontan circulation has improved life expectancy for infants born with complex heart disease over the last 50 years but has also resulted in significant morbidity. Acta Paediatr 2021. [PMID: 34235784 DOI: 10.1111/apa.16023] [Reference Citation Analysis]
9 Alsaied T, Possner M, Lubert AM, Trout AT, Szugye C, Palermo JJ, Lorts A, Goldstein BH, Veldtman GR, Anwar N, Dillman JR. Relation of Magnetic Resonance Elastography to Fontan Failure and Portal Hypertension. Am J Cardiol 2019;124:1454-9. [PMID: 31474329 DOI: 10.1016/j.amjcard.2019.07.052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
10 King EA, Brennan DC. The Science Is Only as Good as the Data: The Case of Fontan-associated Liver Disease. Transplantation 2021;105:23-4. [PMID: 32675742 DOI: 10.1097/TP.0000000000003329] [Reference Citation Analysis]
11 Ritmeester E, Veger VA, van der Ven JPG, van Tussenbroek GMJW, van Capelle CI, Udink ten Cate FEA, Helbing WA. Fontan Circulation Associated Organ Abnormalities Beyond the Heart, Lungs, Liver, and Gut: A Systematic Review. Front Cardiovasc Med 2022;9:826096. [DOI: 10.3389/fcvm.2022.826096] [Reference Citation Analysis]
12 Skubera M, Gołąb A, Plicner D, Natorska J, Ząbczyk M, Trojnarska O, Mazurek-Kula A, Smaś-Suska M, Bartczak-Rutkowska A, Podolec P, Tomkiewicz-Pająk L. Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time-Multicenter Study. J Clin Med 2021;10:5976. [PMID: 34945271 DOI: 10.3390/jcm10245976] [Reference Citation Analysis]
13 Krishnan GS, Gnanasekharan P, Sharma D, Chandrashekhar A, Rao KGS, Balakrishnan KR. Heart transplantation for patients with single ventricle physiology. Indian J Thorac Cardiovasc Surg 2021;:1-15. [PMID: 34642557 DOI: 10.1007/s12055-021-01241-x] [Reference Citation Analysis]
14 Alnoor M, Burch G, Armsby L, Batra A, Balaji S. Hemodynamic Impact of Atrial Pacing in Patients with Fontan Physiology and Junctional Rhythm: A Cardiac Catheterization Study. Pediatr Cardiol 2021. [PMID: 34661729 DOI: 10.1007/s00246-021-02747-2] [Reference Citation Analysis]
15 Evans WN, Acherman RJ, Galindo A, Rothman A, Ciccolo ML, Lehoux J, Winn BJ, Yumiaco NS, Restrepo H. Fontan-associated liver disease and total cavopulmonary anatomical flow effectors. J Card Surg 2021;36:2329-35. [PMID: 33834526 DOI: 10.1111/jocs.15553] [Reference Citation Analysis]
16 Fortea JI, Puente Á, Cuadrado A, Huelin P, Pellón R, González Sánchez FJ, Mayorga M, Cagigal ML, García Carrera I, Cobreros M, Crespo J, Fábrega E. Congestive Hepatopathy. Int J Mol Sci 2020;21:E9420. [PMID: 33321947 DOI: 10.3390/ijms21249420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kogiso T, Tokushige K. Fontan-associated liver disease and hepatocellular carcinoma in adults. Sci Rep 2020;10:21742. [PMID: 33303924 DOI: 10.1038/s41598-020-78840-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ciliberti P, Ciancarella P, Bruno P, Curione D, Bordonaro V, Lisignoli V, Panebianco M, Chinali M, Secinaro A, Galletti L, Guccione P. Cardiac Imaging in Patients After Fontan Palliation: Which Test and When? Front Pediatr 2022;10:876742. [DOI: 10.3389/fped.2022.876742] [Reference Citation Analysis]
19 Parada Blázquez M, Rodríguez Vargas D, Mohigefer Barrera J, Borrero Martín J, Vargas Serrano B. Fontan-associated liver disease. Radiología (English Edition) 2021;63:159-69. [DOI: 10.1016/j.rxeng.2020.10.007] [Reference Citation Analysis]
20 Shiina Y, Nagao M, Shimomiya Y, Inai K. Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation. J Cardiol 2021;77:10-6. [PMID: 33317800 DOI: 10.1016/j.jjcc.2020.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sethasathien S, Silvilairat S, Sittiwangkul R, Makonkawkeyoon K, Pongprot Y, Woragidpoonpol S. Liver nodules after the Fontan operation: role of the computerised tomography scan. Cardiol Young 2021;:1-6. [PMID: 34365989 DOI: 10.1017/S1047951121003309] [Reference Citation Analysis]
22 Thrane KJ, Müller LSO, Suther KR, Thomassen KS, Holmström H, Thaulow E, Almaas R, Möller T, de Lange C. Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents. Abdom Radiol (NY) 2021;46:3205-16. [PMID: 33688987 DOI: 10.1007/s00261-021-02994-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cho MK, Kwon JH, Gwak MS, Joh JW, Hwang J, Kim GS. Liver transplantation in an adult patient with hepatocellular carcinoma following liver cirrhosis as a complication of the Fontan procedure -A case report. Anesth Pain Med (Seoul) 2020;15:466-71. [PMID: 33329850 DOI: 10.17085/apm.20037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Alsaied T, Lubert AM, Goldberg DJ, Schumacher K, Rathod R, Katz DA, Opotowsky AR, Jenkins M, Smith C, Rychik J, Amdani S, Lanford L, Cetta F, Kreutzer C, Feingold B, Goldstein BH. Protein losing enteropathy after the Fontan operation. International Journal of Cardiology Congenital Heart Disease 2022. [DOI: 10.1016/j.ijcchd.2022.100338] [Reference Citation Analysis]
25 Kato A, Sato J, Yoshii K, Yoshida S, Nishikawa H, Ohashi N, Sakurai T, Sakurai H, Hata T, Yoshikawa T. The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection. J Cardiol 2021;78:213-8. [PMID: 33648806 DOI: 10.1016/j.jjcc.2021.02.005] [Reference Citation Analysis]
26 Fukushima K, Itaba N, Kono Y, Okazaki S, Enokida S, Kuranobu N, Murakami J, Enokida M, Nagashima H, Kanzaki S, Namba N, Shiota G. Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice. Regen Ther 2021;18:292-301. [PMID: 34504910 DOI: 10.1016/j.reth.2021.08.004] [Reference Citation Analysis]
27 Katz DA, Peck D, Lubert AM, Possner M, Zafar F, Trout AT, Palermo JJ, Anwar N, Dillman JR, Powell AW, Xanthakos SA, Opotowsky AR, Veldtman G, Alsaied T. Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation. J Am Heart Assoc 2021;10:e019942. [PMID: 33880928 DOI: 10.1161/JAHA.120.019942] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Isoura Y, Yamamoto A, Cho Y, Ehara E, Jogo A, Suzuki T, Amano-Teranishi Y, Kioka K, Hamazaki T, Murakami Y, Tokuhara D. Platelet count and abdominal dynamic CT are useful in predicting and screening for gastroesophageal varices after Fontan surgery. PLoS One 2021;16:e0257441. [PMID: 34618830 DOI: 10.1371/journal.pone.0257441] [Reference Citation Analysis]
29 Possner M, Chaudhry A, Dillman JR, Urbina EM, Gao Z, McCoy C, Faust M, Rossiter HB, Powell AW, Mays W, Veldtman G. Dynamic exercise changes in venous pressure and liver stiffness in Fontan patients: effects of Treprostinil. Cardiol Young 2021;:1-7. [PMID: 33504408 DOI: 10.1017/S1047951121000159] [Reference Citation Analysis]
30 McNamara JR, McMahon A, Griffin M. Perioperative Management of the Fontan Patient for Cardiac and Noncardiac Surgery. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00347-5. [PMID: 34023201 DOI: 10.1053/j.jvca.2021.04.021] [Reference Citation Analysis]
31 Nagata H, Sakamoto I, Fukuoka S, Ishikita A, Uike K, Nagatomo Y, Hirata Y, Yamamura K, Ohga S. Portosystemic venous shunt in the patients with Fontan circulation. Heart Vessels 2021;36:285-90. [PMID: 32844287 DOI: 10.1007/s00380-020-01685-y] [Reference Citation Analysis]
32 Çolaklar A, Lehnert SJ, Tirkes T. Benign Hepatic Nodules Mimicking Hepatocellular Carcinoma in the Setting of Fontan-associated Liver Disease: A Case Report. Euroasian J Hepatogastroenterol 2020;10:42-4. [PMID: 32742972 DOI: 10.5005/jp-journals-10018-1315] [Reference Citation Analysis]
33 Contreras J, Faraoni D. Commentary: Hepatocellular carcinoma: A threat for patients with Fontan circulation. JTCVS Tech 2020;2:131-2. [PMID: 34317778 DOI: 10.1016/j.xjtc.2020.02.038] [Reference Citation Analysis]
34 Neethling E, Heggie JE. Considerations in Critical Care and Anesthetic Management of Adult Patients Living with Fontan Circulation. Can J Cardiol 2022:S0828-282X(22)00267-7. [PMID: 35490923 DOI: 10.1016/j.cjca.2022.04.017] [Reference Citation Analysis]
35 Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE, Taner T, Wald JW, Olthoff KM, Bucuvalas J, Fischer R. Fontan-Associated Liver Disease: Screening, Management, and Transplant Considerations. Circulation 2020;142:591-604. [PMID: 32776846 DOI: 10.1161/CIRCULATIONAHA.120.045597] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
36 Kim MH, Nguyen A, Lo M, Kumar SR, Bucuvalas J, Glynn EF, Hoffman MA, Fischer R, Emamaullee J. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease. Transplantation 2021;105:18-22. [PMID: 32639398 DOI: 10.1097/TP.0000000000003308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Burkhart HM, Phillips SD. Commentary: Hepatocellular carcinoma after the Fontan operation: Are we paying attention? JTCVS Tech 2020;2:133-4. [PMID: 34317779 DOI: 10.1016/j.xjtc.2020.03.009] [Reference Citation Analysis]
38 Ravndal MEH, Borgwardt L, Juul K, Nielsen J, Borgwardt L, Henriksen BM, Willemoe GL, Jensen AS, Christensen VB, Kjær MS. Liver fibrosis in patients with tetralogy of Fallot, an unrecognised complication? Cardiol Young 2021;:1-11. [PMID: 33719984 DOI: 10.1017/S1047951121000901] [Reference Citation Analysis]
39 Parada Blázquez MJ, Rodríguez Vargas D, Mohigefer Barrera J, Borrero Martín JJ, Vargas Serrano B. Fontan-associated liver disease. Radiologia (Engl Ed) 2021;63:159-69. [PMID: 33451720 DOI: 10.1016/j.rx.2020.10.010] [Reference Citation Analysis]
40 Shah AH, Qureshi SA, Krasuski RA. Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations. Curr Cardiol Rep 2022. [PMID: 35230616 DOI: 10.1007/s11886-022-01679-4] [Reference Citation Analysis]
41 Yugawa K, Kohashi K, Itoh S, Yoshizumi T, Sakamoto I, Tsutsui H, Mori M, Oda Y. Combined hepatocellular-cholangiocarcinoma after tetralogy of Fallot repair: a case report and review of literature. Pathol Res Pract 2020;216:152908. [PMID: 32143908 DOI: 10.1016/j.prp.2020.152908] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Possner M, Gordon-Walker T, Egbe AC, Poterucha JT, Warnes CA, Connolly HM, Ginde S, Clift P, Kogon B, Book WM, Walker N, Wagenaar LJ, Moe T, Oechslin E, Kay WA, Norris M, Dillman JR, Trout AT, Anwar N, Hoskoppal A, Broering DC, Bzeizi K, Veldtman G. Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes. Int J Cardiol 2021;322:142-8. [PMID: 32828959 DOI: 10.1016/j.ijcard.2020.08.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
43 Rutledge BP, Devara A, Benjaram S, Judd S, Ehrinpreis M. Transplant-Amenable Hepatocellular Carcinoma in a Fontan Patient. Case Rep Gastroenterol 2019;13:275-9. [PMID: 31341459 DOI: 10.1159/000501198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Watanabe N, Toh N, Takaya Y, Nakayama R, Yokohama F, Osawa K, Miyoshi T, Akagi T, Kanazawa S, Ito H. Usefulness of cardiac fusion imaging with computed tomography and Doppler echocardiography in the assessment of conduit stenosis in complex adult congenital heart disease. J Cardiol 2021:S0914-5087(21)00166-0. [PMID: 34266716 DOI: 10.1016/j.jjcc.2021.06.008] [Reference Citation Analysis]
45 Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:318-65. [PMID: 32946672 DOI: 10.1002/hep.31559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
46 Chen Y, Weng K, Chien K, Chen B, Hsieh K, Tai I, Huang S, Peng H, Huang J, Wu M. Hepatic pathology in patients after Fontan operation: A computed tomography imaging study. Journal of the Chinese Medical Association 2019;82:856-60. [DOI: 10.1097/jcma.0000000000000185] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Emamaullee J, Khan S, Weaver C, Goldbeck C, Yanni G, Kohli R, Genyk Y, Zhou S, Shillingford N, Sullivan PM, Takao C, Detterich J, Kantor PF, Cleveland JD, Herrington C, Ram Kumar S, Starnes V, Badran S, Patel ND. Non-invasive biomarkers of Fontan-associated liver disease. JHEP Rep 2021;3:100362. [PMID: 34693238 DOI: 10.1016/j.jhepr.2021.100362] [Reference Citation Analysis]
48 Kawada S, Chakraborty P, Roche L, Oechslin EN, Silversides C, Wald RM, Downar E, Harris L, Swan L, Alonso-Gonzalez R, Thorne S, Yamamura K, Nanthakumar K, Mondésert B, Khairy P, Nair K. Role of amiodarone in the management of atrial arrhythmias in adult Fontan patients. Heart 2020:heartjnl-2020-317378. [PMID: 33115764 DOI: 10.1136/heartjnl-2020-317378] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Possner M, Alsaied T, Siddiqui S, Morales D, Trout AT, Veldtman G. Abdominal Skeletal Muscle Index as a Potential Novel Biomarker in Adult Fontan Patients. CJC Open 2020;2:55-61. [PMID: 32190826 DOI: 10.1016/j.cjco.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Yoon JS, Lee DH, Cho EJ, Song MK, Choi YH, Kim GB, Lee YB, Lee JH, Yu SJ, Kim H, Kim YJ, Yoon JH, Bae EJ. Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance. Cancers (Basel) 2020;12:E1805. [PMID: 32640555 DOI: 10.3390/cancers12071805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
51 Rodriguez DS, Mao C, Mahle WT, Kanter KR, Alazraki A, Braithwaite K, Rytting H, Caltharp S, Magliocca JF, Romero R. Pretransplantation and Post-Transplantation Liver Disease Assessment in Adolescents Undergoing Isolated Heart Transplantation for Fontan Failure. J Pediatr 2021;229:78-85.e2. [PMID: 32976893 DOI: 10.1016/j.jpeds.2020.09.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Alsaied T, Allen KY, Anderson JB, Anixt JS, Brown DW, Cetta F, Cordina R, D’udekem Y, Didier M, Ginde S, Di Maria MV, Eversole M, Goldberg D, Goldstein BH, Hoffmann E, Kovacs AH, Lannon C, Lihn S, Lubert AM, Marino BS, Mullen E, Pickles D, Rathod RH, Rychik J, Tweddell JS, Wooton S, Wright G, Younoszai A, Glenn T, Wilmoth A, Schumacher K. The Fontan outcomes network: first steps towards building a lifespan registry for individuals with Fontan circulation in the United States. Cardiol Young 2020;30:1070-5. [DOI: 10.1017/s1047951120001869] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
53 Lucas B, Ravishankar S, Pateva I. Pediatric Primary Hepatic Tumors: Diagnostic Considerations. Diagnostics (Basel) 2021;11:333. [PMID: 33670452 DOI: 10.3390/diagnostics11020333] [Reference Citation Analysis]
54 Kaulitz R, Sieverding L, Hofbeck M. Portal vein thrombosis in Fontan-associated liver disease. Cardiol Young 2020;30:883-5. [PMID: 32406357 DOI: 10.1017/S1047951120000992] [Reference Citation Analysis]
55 Krimly A, Jain CC, Egbe A, Alzahrani A, Al Najashi K, Albert-Brotons D, Veldtman GR. The pulmonary vascular bed in patients with functionally univentricular physiology and a Fontan circulation. Cardiol Young 2021;:1-10. [PMID: 34378498 DOI: 10.1017/S104795112100192X] [Reference Citation Analysis]